Here is an interesting article Doxorubicin Market Size, Share - Global Report 2035 (researchnester.com) - you are likely already aware of it - about doxorubicin worldwide sales estimate forecast, which considering a bisantrene plus doxorubicin combination are mind boggling. This is why I am very excited and can't wait to get RC220 into the clinic and get proof that it works both as a cardio protective as well as an improved cancer treatment in combination with doxorubicin. Race / Pfizer might see an opportunity to have another patent for this combination. Just my understanding, please correct if you - or anyone else - disagrees of my thoughts.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-432
-
-
- There are more pages in this discussion • 474 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.68 |
Change
0.020(1.20%) |
Mkt cap ! $286.2M |
Open | High | Low | Value | Volume |
$1.68 | $1.68 | $1.61 | $177.8K | 108.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | $1.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | 1.640 |
1 | 31221 | 1.625 |
1 | 5000 | 1.620 |
1 | 30000 | 1.615 |
2 | 16249 | 1.610 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 4999 | 1 |
1.720 | 17729 | 2 |
1.730 | 25792 | 1 |
1.750 | 508 | 1 |
1.780 | 4483 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |